Antihypertensive Effect of Polyphenol-Rich Fraction of Azadirachta indica on Nω-Nitro-L-Arginine Methyl Ester-Induced Hypertension and Cardiorenal Dysfunction

被引:10
作者
Omobowale, Temidayo Olutayo [1 ]
Oyagbemi, Ademola Adetokunbo [2 ]
Ogunpolu, Blessing Seun [1 ]
Ola-Davies, Olufunke Eunice [2 ]
Olukunle, Johnny Olufemi [3 ]
Asenuga, Ebunoluwa Racheal [4 ]
Ajibade, Temitayo Olabisi [2 ]
Adejumobi, Olumuyiwa Abiola [1 ]
Afolabi, Jeremiah Moyinoluwa [1 ]
Falayi, Olufunke Olubunmi [5 ]
Ashafa, Anofi [6 ]
Adedapo, Adeolu Alex [4 ]
Yakubu, Momoh Audu [7 ]
机构
[1] Univ Ibadan, Fac Vet Med, Dept Vet Med, Ibadan, Nigeria
[2] Univ Ibadan, Fac Vet Med, Dept Vet Physiol & Biochem, Ibadan, Nigeria
[3] Fed Univ Agr, Coll Vet Med, Dept Vet Physiol & Pharmacol, Abeokuta, Nigeria
[4] Univ Benin, Fac Vet Med, Dept Vet Physiol & Biochem, Benin, Nigeria
[5] Univ Ibadan, Fac Vet Med, Dept Vet Pharmacol & Toxicol, Ibadan, Nigeria
[6] Univ Free State, Fac Nat & Agr Sci, Qwaqwa Campus, Phuthaditjaba, South Africa
[7] Texas Southern Univ, Dept Environm & Interdisciplinary Sci, Coll Sci Engn & Technol, Vasc Biol Unit,Ctr Cardiovasc Dis,COPHS, Houston, TX USA
基金
新加坡国家研究基金会;
关键词
Azadirachta indica; hypertension; oxidative stress; renal damage; cell signaling; OXIDATION PROTEIN PRODUCTS; INDUCED LIPID-PEROXIDATION; OXIDE SYNTHASE INHIBITION; WEIBEL-PALADE BODY; FACTOR-KAPPA-B; BLOOD-PRESSURE; KIDNEY INJURY; ACTIVATION; PREVENTS; STRESS;
D O I
10.1055/a-0635-0638
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Azadirachta indica (AI) is a medicinal plant with reported antioxidant and cardio-protective properties. The use of plant-based polyphenols has become greatly increased in the last one decade. The present study investigated the protective effect of the polyphenol-rich fraction (PRF) of the methanol-extract of Azadirachta indica against N-omega-Nitro-L-Arginine Methyl Ester (L-NAME) induced hypertension and cardiorenal dysfunction in rats. Fifty (50) Wistar albino rats were grouped into five groups. Group A, the control, was administered potable water. Groups B-E received orally, 40 mg/kg of L-NAME only, 40 mg/kg of L-NAME and 100 mg/kg of AI extract, 40 mg/kg of L-NAME and 200 mg/kg of AI extract, and 40 mg/kg of L-NAME and 25 mg/kg of captopril, respectively for 21 days. The results of the present study revealed that L-NAME administration led to a significant increase in systolic blood pressure, diastolic blood pressure, and mean arterial blood pressure. Markers of oxidative stress (malondialdehyde, protein carbonyl) increased significantly while there was reduction in reduced glutathione level, activities of superoxide dismutase, glutathione peroxidase and glutathione-S-transferase as well nitric oxide bioavailability. Immunohistochemistry revealed higher expressions of nuclear factor kappa beta (NF-kB) and kidney injury molecule 1(Kim-1) and lower expressions of nuclear factor erythroid 2-related factor 2 (Nrf2) in hypertensive rats. Our results indicated that with PRF of AI restored high blood pressure, reduced markers of oxidative stress, normalized serum NO bioavailability and increased the expressions of Nrf2. Hence, PRF of Azadirachta indica could be used for the treatment of hypertension.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 63 条
  • [1] Inula crithmoides extract protects against ochratoxin A-induced oxidative stress, clastogenic and mutagenic alterations in male rats
    Abdel-Wahhab, Mosaad A.
    Abdel-Azim, Sekena H.
    El-Nekeety, Aziza A.
    [J]. TOXICON, 2008, 52 (04) : 566 - 573
  • [2] Adedapo A D, 2012, RECENT PROGR MED PLA, V35, P293
  • [3] Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats -: Part 1:: Cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats
    Afkir, Saida
    Nguelefack, Telesphore Benoit
    Aziz, Mohamed
    Zoheir, Johar
    Cuisinaud, Guy
    Bnouham, Mohamed
    Mekhfi, Hassane
    Legssyer, Abdelkhaleq
    Lahlou, Saad
    Ziyyat, Abderrahim
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2008, 116 (02) : 288 - 295
  • [4] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [5] Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats
    Annadurai, T.
    Muralidharan, A. R.
    Joseph, T.
    Hsu, M. J.
    Thomas, P. A.
    Geraldine, P.
    [J]. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2012, 68 (03) : 307 - 318
  • [6] [Anonymous], 2002, WHO traditional medicine strategy
  • [7] Attia DM, 2001, J AM SOC NEPHROL, V12, P2585, DOI 10.1681/ASN.V12122585
  • [8] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [9] Hypertension and renal disease
    Bartges, JW
    Willis, AM
    Polzin, DJ
    [J]. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1996, 26 (06) : 1331 - +
  • [10] BEUTLER E, 1963, J LAB CLIN MED, V61, P882